A groundbreaking effort to regenerate human teeth has moved a significant step closer to reality as a Japanese biotechnology company prepares to launch its first clinical trial in patients with the condition the therapy is designed to treat. Japan-based Toregem BioPharma, a spin-out from Kyoto ...

NEW YORK: The alarm bells are ringing across the United States. A highly mutated COVID variant, BA.3.2, first identified in South Africa in November 2024, is quietly making its presence felt across multiple U.S. states, triggering urgent monitoring by the Centers for Disease Control and Prevention ...